Overview of Corex
What is the Corex Combination Drug? (Identity and Classification)
| Property | Description |
|---|---|
| Active ingredient | Codeine phosphate, Chlorpheniramine maleate |
| Form | Oral Solution (Syrup), Tablet |
| Pharmacological class | Antitussive–Antihistamine Combination |
| Common use | Relief of cough and associated allergy symptoms |
| Origin | Semi-synthetic (Codeine) and Synthetic (Chlorpheniramine) |
Corex is a widely utilized combination product that functions as an Antitussive–Antihistamine Combination medication, commonly marketed as a prescription-only medicine. Its therapeutic identity is defined by its two active ingredients: Codeine phosphate and Chlorpheniramine maleate. The formulation consists of a central cough suppressant and an antihistamine for symptom relief. The combination is typically positioned for the relief of persistent, troublesome coughs occurring alongside symptoms of upper respiratory allergies or the common cold.
Corex Composition, Forms, and Origin
The product's composition involves two distinct chemical types: Codeine is a semi-synthetic derivative of opium alkaloids, while Chlorpheniramine is a purely synthetic chemical compound. This blend provides both central and peripheral actions. The medicine is most frequently formulated as an Oral Solution (Syrup), classifying it as a primary oral dosage form. Manufacturers may also supply the active ingredients in other high-level pharmaceutical preparations, such as an Extended-Release Tablet. This combination product is applied to manage the co-occurrence of cough and rhinitis. This characteristic dual mechanism differentiates it from single-agent cough syrups.
High-Level Relief: The Dual Action Principle
The medicine is designed for symptomatic relief through two concurrent physiological actions—one central and one peripheral. The Codeine component initiates central cough control by acting directly on the cough center, which helps suppress the cough reflex. Concurrently, Chlorpheniramine acts peripherally by initiating histamine blockade, mitigating allergic symptoms like sneezing and runny nose. This combined mechanism principle is intended to ease general respiratory discomfort and manage symptomatic respiratory distress.
Regulatory References
